We investigated chemotherapy effects on the expression of PD-L1 (PD-1), CD86 (CTLA-4), CD155 (TIGIT), and Gal-9 (TIM-3) immune checkpoint ligands by neuroblastoma cells (Figure 5). This evidence concerns the gene CD274 and neuroblastoma.